Solstice Oncology: Funding, Investors & Team (Sep 2026)
Solstice Oncology is a clinical stage immuno-oncology company
Solstice Oncology has raised $225M across 1 funding round on record, the most recent a Series A of $225M announced in Sep 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Solstice Oncology Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Solstice Oncology Funding Rounds
Solstice Oncology Investors
Solstice Oncology Funding Compared to Other Biotechnology Startups
Solstice Oncology's latest round of $225M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Solstice Oncology in Biotechnology and Boston
Companies Similar to Solstice Oncology
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Solstice Oncology Funding FAQs
What does Solstice Oncology do?
Solstice Oncology is a clinical stage immuno-oncology company
How much funding has Solstice Oncology raised?
Solstice Oncology has raised $225M across 1 round on record. The most recent is a Series A of $225M announced in Sep 2026.
When did Solstice Oncology last raise funding?
Solstice Oncology's most recent funding round on record is a Series A of $225M, announced in Sep 2026.
Who has invested in Solstice Oncology?
Investors on record for Solstice Oncology include RA Capital Management, Forbion Capital Partners, Canaan Partners.
Where is Solstice Oncology headquartered?
Solstice Oncology is based in Boston, United States.
How many employees does Solstice Oncology have?
Solstice Oncology is in the 11-50 employee band.
When was Solstice Oncology founded?
Solstice Oncology was founded in 2026.
How does Solstice Oncology's funding compare to other Biotechnology startups?
Solstice Oncology's latest round of $225M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Solstice Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Solstice Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.